Mouse Primary Microglia Respond Differently to LPS and Poly(I:C) in Vitro

Overview

Journal Sci Rep

Specialty Science

Date 2021 May 18

PMID 34001933

Citations 34

Authors

Yingbo He

Natalie Taylor

Xiang Yao

Anindya Bhattacharya

Affiliations

Soon will be listed here.

Abstract

Microglia, CNS resident innate immune cells, respond strongly to activation of TLR3 and TLR4, which recognize viral dsRNA poly(I:C) and bacterial endotoxin LPS, respectively. However, few studies have thoroughly and parallelly compared functional phenotypes and downstream mechanisms between LPS- and poly(I:C)-exposed primary microglia. Here, we investigated the responses of mouse primary microglia upon LPS and poly(I:C) stimulation by detecting various phenotypes ranging from morphology, proliferation, secretion, chemotaxis, to phagocytosis. Furthermore, we explored their sequential gene expression and the downstream signal cascades. Interestingly, we found that the microglial activation pattern induced by LPS was distinguished from that induced by poly(I:C). Regarding microglial morphology, LPS caused an ameboid-like shape while poly(I:C) induced a bushy shape. Microglial proliferation was also facilitated by LPS but not by poly(I:C). In addition, LPS and poly(I:C) modulated microglial chemotaxis and phagocytosis differently. Furthermore, genome-wide analysis provided gene-level support to these functional differences, which may be associated with NF-κb and type I interferon pathways. Last, LPS- and poly(I:C)-activated microglia mediated neurotoxicity in a co-culture system. This study extends our understanding of TLR roles in microglia and provides insights into selecting proper inflammatory microglial models, which may facilitate identification of new targets for therapeutic application.

Citing Articles

Machine learning-assisted design of immunomodulatory lipid nanoparticles for delivery of mRNA to repolarize hyperactivated microglia.

Rafiei M, Shojaei A, Chau Y Drug Deliv. 2025; 32(1):2465909.

PMID: 40028722 PMC: 11878168. DOI: 10.1080/10717544.2025.2465909.

Development and characterization of in vitro inducible immortalization of a murine microglia cell line for high throughput studies.

Yeh H, De Cruz M, You Y, Ikezu S, Ikezu T Sci Rep. 2025; 15(1):3207.

PMID: 39863723 PMC: 11762310. DOI: 10.1038/s41598-025-87543-1.

Xixin Decoction's novel mechanism for alleviating Alzheimer's disease cognitive dysfunction by modulating amyloid-β transport across the blood-brain barrier to reduce neuroinflammation.

Yang C, Zhao E, Zhang H, Duan L, Han X, Ding H Front Pharmacol. 2025; 15():1508726.

PMID: 39834810 PMC: 11743276. DOI: 10.3389/fphar.2024.1508726.

18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile.

Germelli L, Angeloni E, Da Pozzo E, Tremolanti C, De Felice M, Giacomelli C Cell Mol Life Sci. 2025; 82(1):34.

PMID: 39757281 PMC: 11700965. DOI: 10.1007/s00018-024-05544-1.

Human VCP mutant ALS/FTD microglia display immune and lysosomal phenotypes independently of GPNMB.

Clarke B, Ziff O, Tyzack G, Petric Howe M, Wang Y, Klein P Mol Neurodegener. 2024; 19(1):90.

PMID: 39593143 PMC: 11590569. DOI: 10.1186/s13024-024-00773-1.

References

Lively S, Schlichter L . Microglia Responses to Pro-inflammatory Stimuli (LPS, IFNγ+TNFα) and Reprogramming by Resolving Cytokines (IL-4, IL-10). Front Cell Neurosci. 2018; 12:215. PMC: 6066613. DOI: 10.3389/fncel.2018.00215. View

Takeda K, Kaisho T, Akira S . Toll-like receptors. Annu Rev Immunol. 2003; 21:335-76. DOI: 10.1146/annurev.immunol.21.120601.141126. View

Qin Y, Liu Y, Hao W, Decker Y, Tomic I, Menger M . Stimulation of TLR4 Attenuates Alzheimer's Disease-Related Symptoms and Pathology in Tau-Transgenic Mice. J Immunol. 2016; 197(8):3281-3292. DOI: 10.4049/jimmunol.1600873. View

Hanisch U . Microglia as a source and target of cytokines. Glia. 2002; 40(2):140-155. DOI: 10.1002/glia.10161. View

Butovsky O, Jedrychowski M, Moore C, Cialic R, Lanser A, Gabriely G . Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat Neurosci. 2013; 17(1):131-43. PMC: 4066672. DOI: 10.1038/nn.3599. View

Ransohoff R, El Khoury J . Microglia in Health and Disease. Cold Spring Harb Perspect Biol. 2015; 8(1):a020560. PMC: 4691795. DOI: 10.1101/cshperspect.a020560. View

Redlich S, Ribes S, Schutze S, Eiffert H, Nau R . Toll-like receptor stimulation increases phagocytosis of Cryptococcus neoformans by microglial cells. J Neuroinflammation. 2013; 10:71. PMC: 3693974. DOI: 10.1186/1742-2094-10-71. View

Shemer A, Erny D, Jung S, Prinz M . Microglia Plasticity During Health and Disease: An Immunological Perspective. Trends Immunol. 2015; 36(10):614-624. DOI: 10.1016/j.it.2015.08.003. View

Hung Y, Huang K, Kang H, Huang G, Huang T . Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder. Psychopharmacology (Berl). 2015; 233(9):1707-14. PMC: 4828490. DOI: 10.1007/s00213-015-4087-7. View

10.

Hosmane S, Tegenge M, Rajbhandari L, Uapinyoying P, Kumar N, Thakor N . Toll/interleukin-1 receptor domain-containing adapter inducing interferon-β mediates microglial phagocytosis of degenerating axons. J Neurosci. 2012; 32(22):7745-57. PMC: 3398425. DOI: 10.1523/JNEUROSCI.0203-12.2012. View

11.

Melief J, Koning N, Schuurman K, van de Garde M, Smolders J, Hoek R . Phenotyping primary human microglia: tight regulation of LPS responsiveness. Glia. 2012; 60(10):1506-17. DOI: 10.1002/glia.22370. View

12.

Sheppard O, Coleman M, Durrant C . Lipopolysaccharide-induced neuroinflammation induces presynaptic disruption through a direct action on brain tissue involving microglia-derived interleukin 1 beta. J Neuroinflammation. 2019; 16(1):106. PMC: 6525970. DOI: 10.1186/s12974-019-1490-8. View

13.

Hoogland I, Houbolt C, van Westerloo D, van Gool W, van de Beek D . Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflammation. 2015; 12:114. PMC: 4470063. DOI: 10.1186/s12974-015-0332-6. View

14.

Hong S, Stevens B . Microglia: Phagocytosing to Clear, Sculpt, and Eliminate. Dev Cell. 2016; 38(2):126-8. DOI: 10.1016/j.devcel.2016.07.006. View

15.

Zhang Y, Chen K, Sloan S, Bennett M, Scholze A, OKeeffe S . An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014; 34(36):11929-47. PMC: 4152602. DOI: 10.1523/JNEUROSCI.1860-14.2014. View

16.

Lee H, Kong P, Lee S, Kwon O, Chun W, Kim S . Differences between lipopolysaccharide and double-stranded RNA in innate immune responses of BV2 microglial cells. Int J Neurosci. 2007; 117(7):885-94. DOI: 10.1080/00207450600592156. View

17.

Das A, Chai J, Kim S, Lee Y, Park K, Jung K . Transcriptome sequencing of microglial cells stimulated with TLR3 and TLR4 ligands. BMC Genomics. 2015; 16:517. PMC: 4497376. DOI: 10.1186/s12864-015-1728-5. View

18.

Gosselin D, Link V, Romanoski C, Fonseca G, Eichenfield D, Spann N . Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell. 2014; 159(6):1327-40. PMC: 4364385. DOI: 10.1016/j.cell.2014.11.023. View

19.

Barton G, Medzhitov R . Toll-like receptor signaling pathways. Science. 2003; 300(5625):1524-5. DOI: 10.1126/science.1085536. View

20.

Petersen M, Dailey M . Diverse microglial motility behaviors during clearance of dead cells in hippocampal slices. Glia. 2004; 46(2):195-206. DOI: 10.1002/glia.10362. View